Otamixaban in acute coronary syndromes Journal Articles

authors

• Eikelboom, John
• Weitz, Jeffrey

status

• published 

publication date

• September 2009

has subject area

• 11 Medical and Health Sciences (FoR)
• Acute Coronary Syndrome (MeSH)
• Angioplasty, Balloon, Coronary (MeSH)
• Anticoagulants (MeSH)
• Clinical Trials, Phase II as Topic (MeSH)
• Cyclic N-Oxides (MeSH)
• Drug Monitoring (MeSH)
• General & Internal Medicine (Science Metrix)
• Heparin (MeSH)
• Hirudins (MeSH)
• Humans (MeSH)
• Metabolic Clearance Rate (MeSH)
• Patient Selection (MeSH)
• Peptide Fragments (MeSH)
• Pyridines (MeSH)
• Recombinant Proteins (MeSH)

published in

• The Lancet  Journal

keywords

• Acute Coronary Syndrome
• Angioplasty, Balloon, Coronary
• Anticoagulants
• Clinical Trials, Phase II as Topic
• Cyclic N-Oxides
• Drug Monitoring
• Heparin
• Hirudins
• Humans
• Metabolic Clearance Rate
• Patient Selection
• Peptide Fragments
• Pyridines
• Recombinant Proteins

Digital Object Identifier (DOI)

• 10.1016/s0140-6736(09)61529-4

PubMed ID

• 19717186

start page

• 762

end page

• 764

volume

• 374

issue

• 9692